Author: Charlotte Russell
Cambridge to lead new £50 million centre to study mitochondrial DNA diseases
Posted /The Medical Research Council (MRC) has announced a £50 million investment in the new MRC Centre of Research Excellence in Mitochondrial Genome Therapeutics, which aims to enable new treatments into potentially fatal mitochondrial DNA diseases. LifeArc Centre for Rare Mitochondrial Disease and MitoCAMB are incredibly excited to share that our very own WP3 Co-Lead Prof Michal […]